A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK.
Hospitalisation
Osteoporosis
Vertebral augmentation
Vertebral fragility fractures
Journal
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
02
09
2022
accepted:
13
12
2022
pubmed:
7
1
2023
medline:
11
2
2023
entrez:
6
1
2023
Statut:
ppublish
Résumé
Our database aimed to assess the impact of vertebral fragility fractures (VFFs) on hospitalisation in England. The results showed that admissions secondary to VFF are increasing annually, more significantly in patients aged 75 years and over. Vertebral augmentation has been showed to reduce length of stay in hospital. Vertebral fragility fractures (VFFs) are the most common osteoporotic fracture. VFF can result in significant pain requiring hospitalisation. However, there are little data on patient numbers, hospital bed days, and costs, contributed to by these patients. We report a retrospective analysis of patients aged 55 years and over admitted to hospitals across England from 2017 to 2019. ICD-10 classifications for VFF and OPCS codes were used to identify admissions and patients who had undergone vertebral augmentation (VA). There were 99,370 patients (61% female) admitted during this period, with 64,370 (65%) patients aged over 75 years. There was a 14.3% average increase in admissions annually. Patients aged over 75 years accounted for 1.5 million bed days, costing £465 million (median length of stay (MLOS) 14.4 days). In comparison, those aged 55-74 years, accounted for 659,000 bed days, costing £239 million (MLOS 10.7 days). The majority of patients (84%) were admitted under a non-surgical speciality and were primarily older (median age 76.8 vs 67.6 years, MLOS 8.2 vs 6.0 days), compared to those admitted to surgical wards 1755 patients underwent vertebral augmentation (VA) (1.8% of the total cohort). The median age of patients undergoing VA was 73.3 years, with 775 (44.2%) of these were aged 75 years and over. In comparison, the median age of patients managed conservatively (non-surgically) was 75.7 years, with 63,595 patients (65.1%) aged 75 years and over. The MLOS and cost per patient admission were lower in the VA group compared to those managed non-surgically. Hospitalised VFF patients represented a significant number, cost, and use of bed days. Those undergoing VA had a significantly shorter length of stay. Further studies are necessary to define those who may benefit from early VA.
Identifiants
pubmed: 36607407
doi: 10.1007/s00198-022-06647-w
pii: 10.1007/s00198-022-06647-w
pmc: PMC9908666
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
607-611Informations de copyright
© 2023. The Author(s).
Références
Age Ageing. 2018 Jan 1;47(1):17-25
pubmed: 29253103
Cardiovasc Intervent Radiol. 2017 Mar;40(3):331-342
pubmed: 28105496
Clin Interv Aging. 2014 Mar 19;9:433-41
pubmed: 24672230
J Am Med Dir Assoc. 2013 Jan;14(1):41-7
pubmed: 23123007
Arch Osteoporos. 2013;8:137
pubmed: 24113838
Bone. 2006 Feb;38(2 Suppl 1):S4-9
pubmed: 16455317
Eur Spine J. 2020 Jul;29(7):1606-1613
pubmed: 32170438
Arch Intern Med. 1989 Nov;149(11):2445-8
pubmed: 2818106
Curr Rheumatol Rev. 2016;12(3):244-247
pubmed: 27323881
Epidemiology. 1992 Nov;3(6):515-8
pubmed: 1420517
Am J Epidemiol. 1993 May 1;137(9):1001-5
pubmed: 8317445
J Am Geriatr Soc. 2005 Sep;53(9):1476-82
pubmed: 16137275
J Bone Miner Res. 1996 Jul;11(7):1010-8
pubmed: 8797123